×The gadget enables patients to self-inject TNF inhibitors without the need for measurement or preparation. The APP-1000, a motorised medication injection device, has been certified by the European Union Medical Devices Regulation (EU-MDR) by PHC's in vitro diagnostics section. The portable medical device of class IIa is designed to administer anti-inflammatory drugs known as tumour necrosis factor (TNF) inhibitors.

Source: News 24 April 19, 2022 15:19 UTC